EUVIMEDEUVIMED entdecken
Crossref

Quantification of Multi-nucleic Acid LNP Formulations Using LEGEND

Deepali Bisht, Denice P Rout, Wilson Poon iD

ACS Applied Bio Materials · 16.11.2026

DOI: 10.1021/acsabm.6c01572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 16.11.2026. Verfasst von Deepali Bisht und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metallurgical, Materials, and Biomedical Engineering, Miguel A. Loya College of Engineering, The University of Texas at El Paso, 500 W …. Die Arbeit nennt 26 Literaturangaben. Gefördert von: University of Texas System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are widely used for nucleic acid delivery, but current kit-based methods of measuring encapsulation efficiency quantify only total RNA and cannot distinguish between multiple nucleic acid cargos within co-formulated LNPs. This limitation complicates formulation characterization, dose normalization, reproducibility, and therapeutic predictability. To address this challenge, we developed LEGEND (LNP Encapsulation by Gel Electrophoresis and Nucleic Acid Densitometry), a simple gel-based assay that enables independent quantification of multiple nucleic acids in co-loaded LNP formulations. Using mCherry mRNA and eGFP siRNA as model cargos, we evaluated SM-102 and DLin-MC3-DMA LNPs containing varying siRNA/mRNA ratios. LEGEND separated and quantified individual nucleic acids based on size, revealing that experimentally encapsulated siRNA/mRNA ratios frequently differed from intended formulation ratios. Furthermore, encapsulation preferences varied between ionizable lipids, with SM-102 favoring mRNA encapsulation and DLin-MC3-DMA favoring siRNA encapsulation. Dose-normalized transfection studies in reporter cells demonstrated that these differences significantly influenced gene silencing and transgene expression outcomes. Overall, LEGEND provides a simple, accessible, and robust method for quantifying individual nucleic acid cargos in multi-nucleic acid co-formulated LNPs, enabling improved formulation characterization, quality control, and development of next-generation nucleic acid therapeutics.

Schlagwörter

Stichwörter der Autor:innen

co-formulationgene therapylipid nanoparticlesmRNAnucleic acid deliverynucleic acid quantificationsiRNA

Autor:innen und Institutionen

  • Department of Metallurgical, Materials, and Biomedical Engineering, Miguel A. Loya College of Engineering, The University of Texas at El Paso, 500 W University Ave, El Paso, Texas79968, United States.
  • Border Biomedical Research Center, The University of Texas at El Paso, 500 W University Ave, El Paso, Texas79968, United States.

ORCID-Profile: Wilson Poon

Förderung

  • University of Texas System

Zitieren

APA

Bisht, D., Rout, D. P., & Poon, W. (2026). Quantification of Multi-nucleic Acid LNP Formulations Using LEGEND. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.6c01572

Vancouver

Bisht D, Rout DP, Poon W. Quantification of Multi-nucleic Acid LNP Formulations Using LEGEND. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.6c01572

BibTeX
@article{Bisht2026,
  author = {Bisht, Deepali and Rout, Denice P and Poon, Wilson},
  title = {Quantification of Multi-nucleic Acid LNP Formulations Using LEGEND},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.6c01572}
}
Kostenlos starten →